Cytolitic tests with hyperimmune patient sera is a good prognostic tool in racotumomab immunotherapy in advanced non-small cell lung cancer


Yazar A.

advances in modern oncology research, vol.3, no.5, pp.223-231, 2017 (Journal Indexed in ESCI)

  • Publication Type: Article / Article
  • Volume: 3 Issue: 5
  • Publication Date: 2017
  • Doi Number: 10.18282/amor.v3.i5.212
  • Title of Journal : advances in modern oncology research
  • Page Numbers: pp.223-231